Collplant Biotechnologies Ltd (CLGN) — Cash Flow Quality Index
Collplant Biotechnologies Ltd (CLGN) has a Cash Flow Quality Index of -0.65x as of June 2023. Operating cash flow of $-3.74 Million is below net income of $5.76 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore CLGN long-term investments to assets to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Collplant Biotechnologies Ltd Cash Flow Quality Index (2021–2021)
Historical Cash Flow Quality Index for Collplant Biotechnologies Ltd across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Collplant Biotechnologies Ltd (CLGN) tangible equity ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Collplant Biotechnologies Ltd (2021–2021)
Year-by-year earnings quality comparison for Collplant Biotechnologies Ltd. For live market cap and the full company financial profile, see Collplant Biotechnologies Ltd stock valuation.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2021 | 10.55x | $2.50 Million | $237.00K | — |